Uricases as Therapeutic Agents to Treat Refractory Gout: Current States and Future Directions
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Uricases as Therapeutic Agents to Treat Refractory Gout: Current States and Future Directions
Authors
Keywords
-
Journal
DRUG DEVELOPMENT RESEARCH
Volume 73, Issue 2, Pages 66-72
Publisher
Wiley
Online
2012-04-16
DOI
10.1002/ddr.20493
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A new practical system for evaluating the pharmacological properties of uricase as a potential drug for hyperuricemia
- (2010) Juan Feng et al. ARCHIVES OF PHARMACAL RESEARCH
- Sensitive Quantification of PEGylated Compounds by Second-Generation Anti-Poly(ethylene glycol) Monoclonal Antibodies
- (2010) Yu-Cheng Su et al. BIOCONJUGATE CHEMISTRY
- Prediction of Immunogenicity of Therapeutic Proteins
- (2010) Christine J. Bryson et al. BIODRUGS
- Effects of Modification of Amino Groups with Poly(Ethylene Glycol) on a Recombinant Uricase fromBacillusfastidiosus
- (2010) Chun ZHANG et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Computational enzymology
- (2010) Richard Lonsdale et al. CHEMICAL COMMUNICATIONS
- Random Mutagenesis Methods for In Vitro Directed Enzyme Evolution
- (2010) Nikolaos Labrou CURRENT PROTEIN & PEPTIDE SCIENCE
- Pegylated Interferons for the Treatment of Chronic Hepatitis C
- (2010) Graham R. Foster DRUGS
- Pegloticase
- (2010) Naomi Schlesinger et al. NATURE REVIEWS DRUG DISCOVERY
- Update on gout: new therapeutic strategies and options
- (2010) Robert Terkeltaub Nature Reviews Rheumatology
- Free-Energy Perturbation Simulation on Transition States and Redesign of Butyrylcholinesterase
- (2009) Wenchao Yang et al. BIOPHYSICAL JOURNAL
- Reversible Inactivation of an Intracellular Uricase fromBacillus fastidiosusviaDissociation of Homotetramer into Homodimers in Solutions of Low Ionic Strength
- (2009) Yunsheng ZHAO et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- How I treat ADA deficiency
- (2009) H. B. Gaspar et al. BLOOD
- An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome
- (2009) Tariq I. Mughal et al. CANCER TREATMENT REVIEWS
- Uric acid: a novel mediator and marker of risk in chronic kidney disease?
- (2009) Daniel I Feig CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Refractory gout: what is it and what to do about it?
- (2009) Edward Fels et al. CURRENT OPINION IN RHEUMATOLOGY
- Update on emerging urate-lowering therapies
- (2009) Saima Chohan et al. CURRENT OPINION IN RHEUMATOLOGY
- Computational Approach for Ranking Mutant Enzymes According to Catalytic Reaction Rates
- (2009) Malika Kumarasiri et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Gout
- (2009) Pascal Richette et al. LANCET
- Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
- (2009) Maribel Rodriguez-Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational structure-based redesign of enzyme activity
- (2009) C.-Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment-failure gout: A moving target
- (2008) N. Lawrence Edwards ARTHRITIS AND RHEUMATISM
- Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment-Failure Gout
- (2008) Corinne Seng Yue et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Modeling the Catalysis of Anti-Cocaine Catalytic Antibody: Competing Reaction Pathways and Free Energy Barriers
- (2008) Yongmei Pan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Most Efficient Cocaine Hydrolase Designed by Virtual Screening of Transition States
- (2008) Fang Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Thermostable Variants of Cocaine Esterase for Long-Time Protection against Cocaine Toxicity
- (2008) D. Gao et al. MOLECULAR PHARMACOLOGY
- Efficacy and (Pharmaco)Kinetics of One Single Dose of Rasburicase in Patients with Chronic Kidney Disease
- (2008) E. Sestigiani et al. NEPHRON CLINICAL PRACTICE
- Uric Acid and Cardiovascular Risk
- (2008) Daniel I. Feig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strengthening intersubunit hydrogen bonds for enhanced stability of recombinant urate oxidase from Aspergillus flavus: molecular simulations and experimental validation
- (2008) Zhixia Liu et al. PHYSICAL CHEMISTRY CHEMICAL PHYSICS
- Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria
- (2008) C. N. Sarkissian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
- (2008) M DANHOF et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Anti-cancer PEG-enzymes: 30 years old, but still a current approach
- (2007) Gianfranco Pasut et al. ADVANCED DRUG DELIVERY REVIEWS
- PEG-uricase in the management of treatment-resistant gout and hyperuricemia
- (2007) Merry R. Sherman et al. ADVANCED DRUG DELIVERY REVIEWS
- Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
- (2007) Tatsuhiro Ishida et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More